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Abstract 
Objective: To assess the magnitude of familial risk of preeclampsia and gestational hypertension in women born of a preeclamptic pregnancy 
and those born of pregnancy complicated by gestational hypertension while accounting for other risk factors.  
Methods: An intergenerational dataset was extracted from the Aberdeen Maternity and Neonatal Databank (AMND) which records all 
pregnancy and delivery details occurring in Aberdeen, Scotland since 1950. The analysis included all nulliparous women whose mothers’ 
records at their births are also recorded in the AMND. Multinomial logistic regression was used to assess the risk of having preeclampsia or 
gestational hypertension based on maternal history of preeclampsia or gestational hypertension. 
Results: There were 17302 nulliparous women included, of whom 1057(6.1%) had preeclampsia while 4098(23.7%) had gestational 
hypertension. Furthermore, 424(2.5%) and 2940(17.0%) had maternal history of preeclampsia and gestational hypertension respectively. The 
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risk of preeclampsia was higher in women who were born of pregnancies complicated by preeclampsia (adjusted RRR 2.55 95% CI 1.87–3.47). 
This was higher than the risk observed in women whose mothers had gestational hypertension (adjusted RRR 1.44 95% CI 1.23–1.69). 
Conversely, the risk of gestational hypertension was similar in those who were born of preeclamptic pregnancies (adjusted RRR 1.37 95% CI 
1.09–1.71) and those whose mothers had gestational hypertension (adjusted RRR 1.36 95% CI 1.24–1.49).    
Conclusion: There was a dose response effect in the inheritance pattern of preeclampsia with the highest risk in women born of preeclamptic 
pregnancies. Gestational hypertension showed similar increased risk with maternal gestational hypertension and preeclampsia. 
Key words: preeclampsia, intergenerational, gestational hypertension, risk factors 
 
 
 
 
 
INTRODUCTION:  
About 14% of all maternal deaths worldwide are attributable to hypertensive disorders of pregnancy [1]. Preeclampsia, the symptom complex of 
hypertension, proteinuria and oedema, is a multifactorial disorder of pregnancy which is associated with significant maternal and perinatal 
complications. It is now known that women who had preeclampsia as well as their offspring are at increased risk of chronic disease [2]. While 
the exact cause of preeclampsia is not known, the risk factors associated with its development include race, parity, age, body mass index 
(BMI), size of the baby and the placenta as well as pre-existing diabetes and cardiovascular disease [3]. Interestingly, factors such as smoking 
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[4] and unprotected sexual intercourse [5] have been associated with reduced risks. It is clear that there is a need for a better understanding of 
the pathogenic mechanism of preeclampsia.  
 
The first definitive study into the epidemiology of preeclampsia is credited to Chesley in 1978 [6]. Since then, several epidemiological and 
genetic studies have confirmed a familial tendency to develop preeclampsia [7-11]. Two large population based studies conducted in Norway 
[12,13] and Sweden [14,15], have investigated the relative contributions of maternal and fetal genetic factors in the pathogenesis of 
preeclampsia. Lie suggests that maternal contributions are twice as strong as paternal ones, and may occur through the maternal genomic 
alleles as well as the intrauterine environment [16]. The mother also provides fetal mitochondria, but this mechanism is unlikely to be 
responsible for incurring genetic susceptibility to preeclampsia [13]. Despite the plethora of studies identifying genetic markers for the condition,  
multiple genetic risk factors are likely to contribute to the risk.  
 
Although there is considerable accumulated evidence on the genetic susceptibility to preeclampsia, the magnitude of such effects in the 
presence of other risk or protective factors is largely under-researched. The aim of this study was to assess the magnitude of familial risk of 
preeclampsia in women born of preeclamptic pregnancy and pregnancies complicated by gestational hypertension compared to those born of 
normotensive pregnancy while controlling for other known predictive factors. We also assessed the risks of gestational hypertension in the 
same group of women. 
 
METHODS: 
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Description of the cohort 
The Aberdeen Maternity and Neonatal Databank (AMND) was established by Sir Dugald Baird in 1950 to store records of all pregnancy related 
events occurring in Aberdeen, Scotland [17]. This database is maintained to this day, and is perhaps the oldest database of its kind that has 
been in continuous use. It now holds information on more than 274,323 pregnancies and is being added to on a weekly basis. Since Aberdeen 
has a relatively stable population and is served by a single maternity unit, the opportunities for research presented by the AMND soon became 
obvious; but it was not until the early 1980s that the idea of establishing an intergenerational cohort materialised. Carr-Hill et al used this 
intergenerational cohort to study the effects of inheritance on birth weight [18]. Following on from this study, when only relatively small numbers 
of intergenerational pairs could be utilised (n=505) the cohort has grown considerably over time as women within families reproduced.  
 
We used data from pregnancy records from 1950 to 2008. Within the Scientific Information Retrieval system (SIR) which was used to store the 
data, relatives were identified as mother-daughter pairs by matching the mother’s surname and date of delivery to the daughter’s maiden name 
and date of birth. NYSIIS and SOUNDEX software were utilised for identifying names that were similar. However, only cases with exact 
matches on the date of birth/ delivery were accepted. The current analysis includes women whose mothers’ pregnancy and delivery data were 
available in the database.  
 
Variables used in the analysis 
Preeclampsia, eclampsia and gestational hypertension are coded in the AMND according to the ISSHP definition as follows: Gestational 
hypertension is defined as a diastolic blood pressure of ≥110mmHg on any one occasion or diastolic blood pressure of ≥90mmHg on any two 
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or more occasions at least 4 hours apart; and preeclampsia as hypertension as above with proteinuria of ≥300 mg/24 hours or proteinuria found 
in 2 urine specimens collected at least 4 hours apart [19]. The small number of cases with eclampsia (with superadded convulsions) was 
included in the preeclampsia group.  
 
Social class based on women’s husband or partner’s occupation, is coded in the AMND according to the British Registrar General’s 
occupational social class classification of 1951 into 6 categories: I- professional, II- managerial, III- skilled non-manual, IV- skilled manual, V- 
semi-skilled, VI- unskilled. This classification was recoded into 2 categories for ease of analysis: professional/ non-manual (Classes I to III) and 
manual (Classes IV to VI) 
 
BMI was calculated using the formula weight in kilograms divided by height in metres squared. The height and weight used were those 
measured and recorded by clinical staff at the first antenatal booking visit, as long as it was within 20 weeks of gestation. Gestational age is 
recorded according to the date of the last menstrual period as reported by women and then confirmed by ultrasound since 1986. As much of 
the data pre-dates routine use of ultrasound, gestational age is mostly calculated according to dates. Other variables extracted included self-
reported smoking habits recorded during antenatal clerking as the number of cigarettes smoked per day and the age of the woman at first 
delivery.   
 
STATISTICAL ANALYSIS 
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The women were categorised into three groups; those who were normotensive, those who had gestational hypertension and those who had 
preeclampsia (including those with eclampsia). Multinomial logistic regression analysis was used to determine the association between having 
maternal history of preeclampsia or gestational hypertension and the three grouping categories. The normotensive group was used as the 
reference category. The analysis was adjusted for age at first birth, BMI, smoking status and social class. The strength of association was 
reported using adjusted relative risk ratios (RRR) and 95% confidence intervals and p < 0.05 was set for statistical significance. Indicators were 
created for missing values and all observations were included in the regression analysis. All data analyses were performed using STATA 
version 13 (StataCorp LP, College Station, Texas, USA). 
 
RESULTS: 
The analysis included 17302 nulliparous women who had their mothers’ pregnancy records available in the AMND database The dataset was 
complete for most of the variables except BMI and smoking status which had 17% and 23% missing values respectively. The characteristics of 
the study population are shown on Table 1. The median (IQR) age was 23 years (19, 27) and BMI was 23.1 (21.2, 25.8). Almost 40% of the 
women smoked, of whom majority smoked more than ten cigarettes per day. Of all included women, 1057 (6.1%) had preeclampsia while 4098 
(23.7%) gestational hypertension. Four hundred and twenty four (2.5%) were born of pregnancies complicated by preeclampsia while 2940 
(17.0%) were born when their mothers had gestational hypertension. The proportion of women born of pregnancies complicated by 
preeclampsia was higher among those who developed preeclampsia compared to those who developed gestational hypertension or were 
normotensive (Table 2). Among those who had gestational hypertension, the proportion of women born when their mothers had gestational 
hypertension was similar to those whose mothers were preeclamptic but higher than among normotensive women (Table 2).    
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Table 1: Characteristics of Study Participants 
Characteristics 
All women Normotensive 
Gestational 
hypertension Preeclampsia 
(n=17302) (n=12147) (n=4098) (n=1057) 
N (%) N (%) N (%) N (%) 
Age at first pregnancy 
(median, IQR) 23 (19,27) 22 (19,27) 23 (20,26) 23 (20,26) 
Booking body mass index 
(median, IQR) 
23.1  
(21.2, 25.8) 
22.8  
(20.9, 25.3)  23.9 (21.8,27.0) 
24.4  
(22.2, 27.8)  
Social class   
 
  Professional/Non-manual 3438 (19.9) 2358 (19.4) 861 (21.0) 219 (20.7) 
Manual 7574 (43.8) 5390 (44.4) 1733 (42.3) 451 (42.6) 
Other 6290 (36.4) 4399 (36.2) 1504 (36.7) 387 (36.6) 
Smoking status 
   Non-smoker 6549 (37.9) 4656 (38.3) 1471 (35.9) 422 (39.9) 
1-9 per day  1491 (8.6) 1168 (9.62) 268 (6.5) 55 (5.2) 
Over 10 per day  5226 (30.2) 3900 (32.11) 1100 (26.8) 226 (21.4) 
Missing 4036 (23.3) 2423 (20.0) 1259 (30.7) 354 (33.5) 
Maternal pregnancy 
induced hypertension 
    Neither 13935 (80.5) 9980 (82.2) 3168 (77.3) 787 (74.5) 
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   Maternal gestational 
Hypertension 2940 (17.0) 1904 (15.7) 818 (20.0) 218 (20.6) 
   Maternal Preeclampsia 427 (2.5) 263 (2.2) 112 (2.7) 52 (4.9) 
 
The multinomial logistic regression analysis (Table 2) showed that women who were born of pregnancies complicated by preeclampsia were 
more likely to develop preeclampsia compared to women who were born of normotensive pregnancies (RRR 2.55 95% CI 1.87–3.47). 
Likewise, women whose mothers had gestational hypertension also had an increased risk of having preeclampsia but the association was not 
as strong (RRR 1.44 95% CI 1.23–1.69). On the other hand, the risk of having gestational hypertension was similar in those who were born of 
pregnancies complicated by preeclampsia (RRR 1.37 95% CI 1.09–1.71) and those whose mothers had gestational hypertension (RRR 1.36 
95% CI 1.24–1.49). In order to assess the potential effect of missing values on the results, a complete case analysis was also conducted. The 
model with complete cases included 11506 women but results were similar to that which used indicators for missing values.  
 
Table 2: Association of preeclampsia and gestational hypertension with maternal history of pregnancy induced hypertension 
 
Characteristics Normotensive Gestational hypertension (n=4098) Preeclampsia (n=1057) 
 
(n=12147) Unadjusted Adjusted Unadjusted Adjusted 
  
RRR (95% CI) P-value 
a
RRR (95% CI) P-value RRR (95% CI) P-value 
a
RRR (95% CI) P-value 
Age at first 
pregnancy 
(median, IQR) 
Reference 
group 1.01 (1.002–1.02) 0.01 1.01 (1.0004–1.02) 0.04 1.003 (0.99–1.02) 0.67 0.999 (0.98–1.01) 0.46 
Booking body mass 
index (median, 
IQR) 
Reference 
group 
1.0001 (1.00001–
1.0002) 0.02 
1.00 (0.9999–
1.0001) 0.56 
1.0002 (1.00007–
1.0004) 0.01 
1.0002 (1.000006–
1.0003) 0.04 
Social class   
           Professional/Non-
manual 
Reference 
group 
  
1 
   
1 
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Manual 
 
0.88 (0.80–0.97) 0.01 0.93 (0.85–1.03) 0.18 0.90 (0.76–1.07) 0.23 0.97 0.82–1.16) 0.76 
Other 
 
0.94 (0.85–1.03) 0.19 0.99 (0.89–1.10) 0.88 0.95 (0.80–1.13) 0.54 1.03 (0.85–1.24) 0.78 
Smoking status 
         
Non-smoker 
Reference 
group 1 
 
1 
   
1 
 1-9 per day  
 
0.73 (0.63–0.84) <0.0001 0.75 (0.65–0.87) <0.0001 0.52 (0.39–0.69) <0.0001 0.50 (0.37–0.67) <0.0001 
Over 10 per day  
 
0.89 (0.82–0.98) 0.01 0.93 (0.85–1.03) 0.16 0.64 (0.54–0.76) <0.0001 0.62 (0.52–0.74) <0.0001 
Missing 
   
- - - - - - 
Maternal pregnancy induced 
hypertension 
        
   None 
Reference 
group 
  
1 
   
1 
 
Maternal gestational 
hypertension 
 
1.35 (1.24–1.48) <0.0001 1.36 (1.24–1.49) <0.0001 1.45 (1.24–1.70) <0.0001 1.44 (1.23–1.69) <0.0001 
   Maternal 
Preeclampsia 
 
1.34 (1.07–1.68) 0.01 1.37 (1.09–1.71) 0.01 2.51 (1.85–3.41) <0.0001 2.55 (1.87–3.47) <0.0001 
aMultinomial logistic regression analysis was used to assess the association of a woman being born a pregnancy complicated by gestational hypertension or 
preeclampsia and having either of the conditions themselves in their first pregnancies. The analysis was adjusted for age at first birth, BMI, smoking status 
and social class.  
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DISCUSSION: 
This study, using intergenerational data from a geographically defined population, suggests 
that the inherited risk of preeclampsia was different in women born of pregnancies 
complicated by preeclampsia and those born of pregnancies complicated with gestational 
hypertension compared to women born of normotensive pregnancies. Women born of 
pregnancies complicated with preeclampsia had more than twice the risk of developing 
preeclampsia themselves in their first pregnancies. The risk in those born of pregnancies 
complicated by gestational hypertension is lower but still higher than those born of 
normotensive pregnancies. In other words, the inheritance pattern of preeclampsia showed a 
dose response effect with the highest risk in women born of preeclamptic pregnancies. On 
the other hand, the risk of having gestational hypertension is very similar in women born of 
pregnancies complicated by gestational hypertension and those born of pregnancies 
complicated by preeclampsia. 
 
Our findings are consistent with most other studies that have looked at inherited 
predisposition to preeclampsia. Previous evidence suggest that women who were born after 
a preeclamptic pregnancy were more than twice as likely to develop preeclampsia 
themselves even though other risk factors were not adjusted for (OR 2.2 95% CI 2.0–2.4) 
[12]. The study also showed that women who were not born to a pregnancy complicated by 
preeclampsia but had a family history were still at risk of preeclampsia compared with 
women with no family history of preeclampsia at all. These demonstrate that  there are 
various genetic contributions to the risk. Cnattingius suggested that more than 67% of the 
susceptibility to preeclampsia is accountable to genetic factors, while 32% to unmeasured 
“other” factors [14]. However, preeclampsia is a complex disorder with varying grades of 
clinical severity and so familial risk for preeclampsia is expected to involve combination of 
genes rather than a single gene [20,21]. A recent meta-analysis of genes which are currently 
under investigation for preeclampsia showed that over a third of the genes examined were 
not found to be consistently or significantly associated with preeclampsia [22]. Further work 
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likely involving genome wide association studies is needed to understand the genetics of 
preeclampsia.    
 
This study also showed that while those who had preeclampsia were more than twice as 
likely to have been born of a preeclamptic pregnancy compared to being born of a 
normotensive pregnancy, for those who had gestational hypertension, the association was 
not as strong. In fact, the risk of developing gestational hypertension is almost the same for 
those who were born of preeclamptic pregnancies and those born of pregnancies 
complicated by gestational hypertension. Comparable observations have been reported by 
other authors. For example, women who had severe or early onset preeclampsia were more 
likely to have been born of a preeclamptic pregnancy compared to those born of 
normotensive pregnancies (OR 3.0 95% CI 2.4–3.7) [12]. However, the association was less 
in women who had mild preeclampsia (OR 2.1 95% CI 1.8–2.4). These suggest that 
inherited susceptibility to preeclampsia may cause a more severe disease.  
 
Only nulliparous women were included in this study, some of the women would have had 
preeclampsia in subsequent pregnancies. However, preeclampsia is predominantly a 
condition occurring in the first pregnancy, its presence in a subsequent pregnancy is often 
preceded by a history of the condition in the initial pregnancy [23]. Multiparous women with 
no history of preeclampsia only had about 1% risk of preeclampsia but those that had 
preeclampsia in one or two consecutive pregnancies had much higher risks, about 15% and 
30% respectively [24]. More so, a study which investigated the familial risk of preeclampsia 
in the second birth showed that women born of pregnancies complicated by preeclampsia 
still had similar risk (OR 2.3 95% CI 1.8–2.9) [12]. We have no reasons to believe that the 
risks would be significantly different in the subsequent pregnancies. 
 
One of the strengths of this study is that the diagnoses were made based on established 
criteria. Also, AMND data are coded contemporaneously as the events occur and thereby 
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eliminate recall bias. Recently data have become available in the Scandinavian countries 
from their birth registries by means of which the genetic component of preeclampsia can be 
tested. Although these are extremely large population based cohorts, they lack data on other 
important risk factors such as smoking. It is worth noting that smoking habits in the dataset 
used for this study were recorded based on self-report. Self-reported information on habits 
which are deemed socially undesirable, such as smoking during pregnancy, are often 
inadequate. Some women may underreport that they smoked or the number of cigarettes 
they smoked daily. Yet, in the cohort used in this study, the proportion of smokers is as high 
as 39%. Although this is partly due to the historic cohort, the proportion of smokers among 
women who delivered between year 2000 and 2007 was still about 29%. It is unlikely that 
smoking was significantly underreported in this study. More so, the inverse relationship 
observed with smoking in this study is consistent with what has been reported in several 
previous studies [4].  
 
While we adjusted for potential confounding factors, there were some known (such as, past 
medical history of hypertension and/ or renal disease) and other unknown factors that could 
not be taken into consideration which is a limitation of our study. Nevertheless, factors such 
as history of hypertension could be a path variable and it would not be necessary to adjust 
for it in this study. We also did not assess the daughters’ risk of preeclampsia or gestational 
hypertension if their mothers were hypertensive in another pregnancy resulting in a sibling’s 
birth. We acknowledge that although not as strong as maternal associations, predisposition 
to preeclampsia may also be inherited from fathers as shown in other epidemiological 
studies [25]. We did not assess associations with paternal history of preeclampsia as it is 
beyond the scope of this study.  
 
In conclusion, this study showed that women born while their mothers had preeclampsia 
were more than twice as likely to develop preeclampsia compared to those born of 
normotensive pregnancies even after adjusting for other factors. Maternal history of 
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gestational hypertension also contributes to the risk of preeclampsia, albeit not as much as 
maternal history of preeclampsia. Inherited predisposition to preeclampsia is more 
pronounced for clinically more severe disease. Further studies are required to enable the 
clinician to accurately predict the development of preeclampsia at the antenatal visit and 
plan the management of pregnancies accordingly. Such studies may include prospectively 
collected information such as uterine artery Doppler, fetal DNA in maternal circulation and 
other biochemical tests that have been demonstrated to predict preeclampsia.  
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Highlights 
• We identified a dose response effect in the inheritance pattern of preeclampsia. 
• Maternal gestational hypertension was associated with increased risk of 
preeclampsia in daughters.   
• The risk of preeclampsia was higher in women born from preeclamptic pregnancies. 
• Inherited susceptibility to preeclampsia is associated with severity of the condition.  
 
 
